Semma Therapeutics Receives $44 Million Funding Led By MPM Capital To Develop Type 1 Diabetes Cell Therapy
News, Type 1 Diabetes News
Cambridge, Massachusetts-based Semma Therapeutics, a biotech company currently developing a cell therapy for Type 1 diabetes, has secured $44 million Series A equity financing and strategic funding. The financing is ... Read more